Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. [electronic resource]
Producer: 19970605Description: 359-68 p. digitalISSN:- 1042-8194
- Adult
- Antimetabolites, Antineoplastic -- pharmacokinetics
- Biological Transport
- Biotransformation
- Carrier Proteins -- metabolism
- Child
- Chromosomes, Human, Pair 21 -- genetics
- Disease Susceptibility
- Disease-Free Survival
- Down Syndrome -- complications
- Drug Resistance, Neoplasm
- Folic Acid Antagonists -- pharmacokinetics
- Half-Life
- Humans
- Membrane Proteins
- Membrane Transport Proteins
- Methotrexate -- pharmacokinetics
- Neoplasm Proteins -- metabolism
- Neoplastic Stem Cells -- metabolism
- Polyglutamic Acid -- metabolism
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prognosis
- Reduced Folate Carrier Protein
- Remission Induction
- Tetrahydrofolate Dehydrogenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.